Patrick I. Borgen

Maimonides Medical Center

Full Professor(heuristic)

Breast Cancer Treatment Studies · Cancer Research

h-index73

i10-index141

Publications225

Citations17,757

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 8 of 8

ASO Visual Abstract: Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews
Annals of Surgical Oncology · 2025-09-10
The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
International Journal of Radiation Oncology*Biology*Physics · 2025-09-01
Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants’ and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews
Annals of Surgical Oncology · 2025-08-23
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates
International Journal of Radiation Oncology*Biology*Physics · 2025-07-18 · 1 citations
Abstract P3-08-20: The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
Clinical Cancer Research · 2025-06-13
TIP25-242: The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients With Ductal Carcinoma In Situ
Journal of the National Comprehensive Cancer Network · 2025-03-28
The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
International Journal of Radiation Oncology*Biology*Physics · 2024-09-27
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
Annals of Surgical Oncology · 2024-07-15

Open author page on OpenAlex →